|
DE19856475A1
(de)
*
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10346940B3
(de)
*
|
2003-10-06 |
2005-06-16 |
Schering Ag |
Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1373888A2
(en)
*
|
2000-12-28 |
2004-01-02 |
Schering Aktiengesellschaft |
Method for screening for progesterone receptor isoform-specific ligands
|
|
EP1467982B8
(en)
*
|
2002-01-14 |
2007-04-11 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
|
|
DK1482925T3
(da)
*
|
2002-03-11 |
2007-05-14 |
Bayer Schering Pharma Ag |
5- (2-hydroxy-3 -'1 - (3-trifluormethylphenyl) cyclopropylpropionylamino) phtalid og relaterede forbindelser med progesteronreceptormoducerende aktivitet til anvendelse i fertilitetskontrol og hormonerstatningsterapi
|
|
EP1344776A1
(en)
*
|
2002-03-11 |
2003-09-17 |
Schering Aktiengesellschaft |
5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
|
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
JP4324480B2
(ja)
|
2002-03-26 |
2009-09-02 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
|
|
DE10215316C1
(de)
*
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
NZ538932A
(en)
|
2002-08-29 |
2007-04-27 |
Boehringer Ingelheim Pharma |
3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease
|
|
JP2006518328A
(ja)
*
|
2002-10-15 |
2006-08-10 |
ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション |
複素環選択的アンドロゲン受容体調節剤及びその使用方法
|
|
DE10261874A1
(de)
*
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1583745A1
(en)
|
2003-01-03 |
2005-10-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
US20040224992A1
(en)
*
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2531060A1
(en)
*
|
2003-07-01 |
2005-01-13 |
Schering Aktiengesellschaft |
Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
JP4468369B2
(ja)
|
2003-10-16 |
2010-05-26 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
ある種のトリフルオロメチル置換アルコールの立体選択的合成
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
PE20060272A1
(es)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
DE102004062182B4
(de)
*
|
2004-12-20 |
2007-06-06 |
Bayer Schering Pharma Ag |
Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
JP5281291B2
(ja)
|
2005-01-10 |
2013-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
|
WO2006083030A1
(ja)
*
|
2005-02-04 |
2006-08-10 |
Ajinomoto Co., Inc. |
脂肪酸の製造方法および脂肪酸の塩結晶
|
|
UY29439A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
MY145281A
(en)
|
2005-03-25 |
2012-01-13 |
Glaxo Group Ltd |
Novel compounds
|
|
DE102005017326A1
(de)
*
|
2005-04-14 |
2007-03-29 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
DE102005030294A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
US7408060B2
(en)
|
2005-06-24 |
2008-08-05 |
Schering Ag |
Nonsteroidal progesterone receptor modulators
|
|
DE102005030293A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
EP1963287A1
(en)
|
2005-12-09 |
2008-09-03 |
F.Hoffmann-La Roche Ag |
Glucocorticoid receptor modulators as antiinflammatory agents
|
|
PE20071068A1
(es)
|
2005-12-20 |
2007-12-13 |
Glaxo Group Ltd |
Acido 3-(4-{[4-(4-{[3-(3,3-dimetil-1-piperidinil)propil]oxi}fenil)-1-piperidinil]carbonil}-1-naftalenil)propanoico o propenoico, sales de los mismos, como antagonistas de los receptores h1 y h3
|
|
EA200801997A1
(ru)
|
2006-04-20 |
2009-04-28 |
Глаксо Груп Лимитед |
Новые соединения
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2009005264A
(es)
|
2006-12-06 |
2009-05-28 |
Boehringer Ingelheim Int |
Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
|
|
DE102007023614A1
(de)
|
2007-05-21 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007049630A1
(de)
|
2007-10-11 |
2009-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
UY30815A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroidales del receptor de progesterona
|
|
UY30805A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroides de receptores de progesterona
|
|
JP5090773B2
(ja)
*
|
2006-12-26 |
2012-12-05 |
国立大学法人東京工業大学 |
光学活性含フッ素カルボニル−エン生成物の製造方法
|
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
|
DE102007032800A1
(de)
|
2007-07-10 |
2009-01-15 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007058747A1
(de)
|
2007-12-05 |
2009-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
EP2070909A1
(de)
*
|
2007-12-15 |
2009-06-17 |
Bayer Schering Pharma AG |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
JP5791500B2
(ja)
|
2008-05-23 |
2015-10-07 |
パンミラ ファーマシューティカルズ，エルエルシー． |
５−リポキシゲナーゼ活性化タンパク質阻害剤
|
|
WO2009147190A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
EP2280946B1
(en)
|
2008-06-05 |
2016-02-10 |
Glaxo Group Limited |
4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
|
|
DK2300472T3
(da)
|
2008-06-06 |
2012-04-10 |
Boehringer Ingelheim Int |
Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
US8524751B2
(en)
|
2009-03-09 |
2013-09-03 |
GlaxoSmithKline Intellecutual Property Development |
4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
|
|
US8354539B2
(en)
|
2009-03-10 |
2013-01-15 |
Glaxo Group Limited |
Indole derivatives as IKK2 inhibitors
|
|
JP2012520845A
(ja)
|
2009-03-17 |
2012-09-10 |
グラクソ グループ リミテッド |
Ｉｔｋ阻害剤として使用されるピリミジン誘導体
|
|
US20120035247A1
(en)
|
2009-03-19 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
JP2012520683A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いた結合組織増殖因子（ＣＴＧＦ）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
AU2010226604A1
(en)
|
2009-03-19 |
2011-10-13 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of BTB and CNC homology 1, basic leucine zipper transcription factor 1 (Bach 1) gene expression using short interfering nucleic acid (siNA) sequence listing
|
|
US20120029054A1
(en)
|
2009-03-19 |
2012-02-02 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
|
|
US20120022142A1
(en)
|
2009-03-27 |
2012-01-26 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
WO2010111468A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
|
WO2010111490A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20120010272A1
(en)
|
2009-03-27 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
EP2411517A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US8399436B2
(en)
|
2009-04-24 |
2013-03-19 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as CRAC channel inhibitors
|
|
RS53830B1
(sr)
|
2009-04-30 |
2015-06-30 |
Glaxo Group Limited |
Indazoli supstituisani oksazolom kao inhibitori pi3-kinaze
|
|
EP2507231A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
US20120272951A1
(en)
|
2009-12-16 |
2012-11-01 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2613781B1
(en)
|
2010-09-08 |
2016-08-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
HRP20151017T1
(hr)
|
2010-09-08 |
2015-10-23 |
Glaxosmithkline Intellectual Property Development Limited |
Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2-(metiloksi)-3-piridinil]metansulfonamida
|
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
|
JP5795643B2
(ja)
|
2010-10-21 |
2015-10-14 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
アレルギー性状態、免疫性状態及び炎症性状態に作用するピラゾール化合物
|
|
WO2012052459A1
(en)
|
2010-10-21 |
2012-04-26 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
KR20160060100A
(ko)
|
2013-09-22 |
2016-05-27 |
칼리토르 사이언시즈, 엘엘씨 |
치환된 아미노피리미딘 화합물 및 이용 방법
|
|
KR20160062179A
(ko)
|
2013-10-17 |
2016-06-01 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
호흡기 질병의 치료를 위한 ｐｉ３ｋ 억제제
|
|
EP3057588A1
(en)
|
2013-10-17 |
2016-08-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Pi3k inhibitor for treatment of respiratory disease
|
|
US9399637B2
(en)
|
2014-03-28 |
2016-07-26 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
WO2015173701A2
(en)
|
2014-05-12 |
2015-11-19 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions for treating infectious diseases
|
|
EP3347097B1
(en)
|
2015-09-11 |
2021-02-24 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
|
|
GB201602527D0
(en)
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3497100A1
(en)
|
2016-08-08 |
2019-06-19 |
GlaxoSmithKline Intellectual Property Development Limited |
Chemical compounds
|
|
GB201706102D0
(en)
|
2017-04-18 |
2017-05-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201712081D0
(en)
|
2017-07-27 |
2017-09-13 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3569228A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Association pour la recherche à l'IGBMC (ARI) |
Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
|
|
WO2019099311A1
(en)
|
2017-11-19 |
2019-05-23 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
|
EP3740468B1
(en)
|
2018-01-20 |
2025-12-31 |
Sunshine Lake Pharma Co., Ltd. |
Substituted Aminopyrimidine Compounds and Methods of Use
|
|
CA3173172A1
(en)
|
2020-03-26 |
2021-09-30 |
Christopher D. Kane |
Cathepsin inhibitors for preventing or treating viral infections
|
|
KR20230024328A
(ko)
*
|
2020-06-12 |
2023-02-20 |
상하이 제민케어 파마슈티칼스 컴퍼니 리미티드 |
프탈라지논 화합물, 이의 제조 방법 및 이의 의학적 용도
|
|
CN114605308B
(zh)
*
|
2022-03-18 |
2023-12-19 |
阜新孚隆宝医药科技有限公司 |
一种帕罗韦德的氮杂双环医药中间体的制备方法及中间体
|